|
Originally published In Press as doi:10.1074/jbc.M407397200 on December 16, 2004
J. Biol. Chem., Vol. 280, Issue 8, 6570-6579, February 25, 2005
OX1 Orexin Receptors Couple to Adenylyl Cyclase Regulation via Multiple Mechanisms*
Tomas Holmqvist ,
Lisa Johansson ,
Marie Östman ,
Sylwia Ammoun ,
Karl E. O. Åkerman , and
Jyrki P. Kukkonen ¶
From the
Department of Neuroscience, Unit of Physiology, Uppsala University, BMC, SE-75123 Uppsala, Sweden and the A. I. Virtanen Institute for Molecular Sciences, University of Kuopio, Neulaniementie 2, FIN-70210 Kuopio, Finland
In this study, the mechanism of OX1 orexin receptors to regulate adenylyl cyclase activity when recombinantly expressed in Chinese hamster ovary cells was investigated. In intact cells, stimulation with orexin-A led to two responses, a weak (21%), high potency (EC50 1nM) inhibition and a strong (4-fold), low potency (EC50 = 300 nM) stimulation. The inhibition was reversed by pertussis toxin, suggesting the involvement of Gi/o proteins. Orexin-B was, surprisingly, almost equally as potent as orexin-A in elevating cAMP (pEC50 = 500 nM). cAMP elevation was not caused by Ca2+ elevation or by G . In contrast, it relied in part on a novel protein kinase C (PKC) isoform, PKC , as determined using pharmacological inhibitors. Yet, PKC stimulation alone only very weakly stimulated cAMP production (1.1-fold). In the presence of Gs activity, orexins still elevated cAMP; however, the potencies were greatly increased (EC50 of orexin-A = 10 nM and EC50 of orexin-B = 100 nM), and the response was fully dependent on PKC . In permeabilized cells, only a PKC-independent low potency component was seen. This component was sensitive to anti-G s antibodies. We conclude that OX1 receptors stimulate adenylyl cyclase via a low potency Gs coupling and a high potency phospholipase C PKC coupling. The former or some exogenous Gs activation is essentially required for the PKC to significantly activate adenylyl cyclase. The results also suggest that orexin-B-activated OX1 receptors couple to Gs almost as efficiently as the orexin-A-activated receptors, in contrast to Ca2+ elevation and phospholipase C activation, for which orexin-A is 10-fold more potent.
Received for publication, July 1, 2004
, and in revised form, November 4, 2004.
* This work was supported by European Union Contract QLG3-CT-2002-00826, the Åke Wiberg Foundation, the Lars Hierta Foundation, the Göran Gustafsson Foundation, the Novo Nordisk Foundation, the Academy of Finland, and the Sigrid Jusélius Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Neuroscience, Division of Physiology, Uppsala University, BMC, P.O. Box 572, SE-75123 Uppsala, Sweden. Tel.: 46-18-471-4171; Fax: 46-18-50-6357; E-mail: jyrki.kukkonen{at}fysiologi.uu.se.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Ramanjaneya, A. C. Conner, J. Chen, P. R. Stanfield, and H. S. Randeva
Orexins Stimulate Steroidogenic Acute Regulatory Protein Expression through Multiple Signaling Pathways in Human Adrenal H295R Cells
Endocrinology,
August 1, 2008;
149(8):
4106 - 4115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Goncz, M. Z. Strowski, C. Grotzinger, K. W. Nowak, P. Kaczmarek, M. Sassek, S. Mergler, B. F. El-Zayat, M. Theodoropoulou, G. K. Stalla, et al.
Orexin-A Inhibits Glucagon Secretion and Gene Expression through a Foxo1-Dependent Pathway
Endocrinology,
April 1, 2008;
149(4):
1618 - 1626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bernard, R. Lydic, and H. A. Baghdoyan
Hypocretin (Orexin) Receptor Subtypes Differentially Enhance Acetylcholine Release and Activate G Protein Subtypes in Rat Pontine Reticular Formation
J. Pharmacol. Exp. Ther.,
April 1, 2006;
317(1):
163 - 171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Spinazzi, P. G. Andreis, G. P. Rossi, and G. G. Nussdorfer
Orexins in the regulation of the hypothalamic-pituitary-adrenal axis.
Pharmacol. Rev.,
March 1, 2006;
58(1):
46 - 57.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ammoun, D. Lindholm, H. Wootz, K. E. O. Akerman, and J. P. Kukkonen
G-protein-coupled OX1 Orexin/hcrtr-1 Hypocretin Receptors Induce Caspase-dependent and -independent Cell Death through p38 Mitogen-/Stress-activated Protein Kinase
J. Biol. Chem.,
January 13, 2006;
281(2):
834 - 842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ammoun, L. Johansson, M. E. Ekholm, T. Holmqvist, A. S. Danis, L. Korhonen, O. A. Sergeeva, H. L. Haas, K. E. O. Akerman, and J. P. Kukkonen
OX1 Orexin Receptors Activate Extracellular Signal-Regulated Kinase in Chinese Hamster Ovary Cells via Multiple Mechanisms: The Role of Ca2+ Influx in OX1 Receptor Signaling
Mol. Endocrinol.,
January 1, 2006;
20(1):
80 - 99.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|